Genvira specializes in viral engineering. We design, construct and characterize customized RNA/DNA viruses which are non-pathogenic, long term stability and have low immunogenicity and high transduction efficiency. These viruses are utilized in:
- Cancer Immunotherapy
- Gene therapy
Cancer Immunotherapy & Gene Therapy
Our bioengineered DNA viruses such as Adeno-associated viruses (AAVs) and Myxoma viruses are used to help deliver genes of interest into target mammalian cells and tissues which then generates new instructions for the cells to control the progression of diseases such as cancers, retinal disorders, etc. We also conduct a wide range of functional bioassays to screen and test the potency and immunogenicity of our bioengineered viruses.
Our world-class laboratory and experts can create a vaccine for all your research and clinical needs. For example, because our SARS CoV-2 pseudoviruses don’t replicate, they are safe and can easily be applicable in vitro and in vivo studies by researchers who don’t have BSL3 and BSL laboratories.
Cell and Viral Engineering
Delivering high-quality engineered vectors and cells
From product design to engineering, production, & testing
Achieve viral stability before and after delivery
In vitro viral vector characterization
In vivo efficacy studies
Process Development and Small-Scale Production
Optimization of process and yield
FDA Regulatory Filings
IND & CMC filing expertise
Studies under GLP guideline
MVS to BDS Production
Transition and scalability consultation
Located in the heart of Canada’s capital, Genvira Biosciences builds innovative viral based biotherapeutics. We specialize in viral vector engineering for cancer immunotherapy, gene therapy, and vaccines.
Working with Canadian and international clients, Genvira Biosciences designs, constructs, and characterizes customized DNA and RNA viruses. With our world-leading proprietary engineering technology, we efficiently deliver high-quality vectors with great viral stability to our clients at various stages of clinical development.
Genvira’s viral engineers will help you cross the finish line to approval - faster, smoother, and safer. Whether you need the extra bench strength to help complete a project or prefer our team to co-develop or create a product from scratch, our flexibility can help you reach your goals.
Our commitment is efficiently delivering high-quality vectors with great viral stability at any stages of clinical development.
Our highly experienced and diligent team are dedicated to serving your unique needs and will help you cross the finish line to approval - faster, smoother, and safer.